Fungal Infection in Lung Transplantation

Area of Science:

• Medical Mycology
• Transplant Infectious Diseases
• Pulmonary Medicine

Background:

• Invasive fungal infections (IFIs) are a major cause of morbidity and mortality following lung transplantation.
• Current antifungal prophylaxis strategies face challenges including cost, adverse effects, and poor absorption.
• Accurate and timely diagnosis of IFIs is critical for effective management in immunocompromised patients.

Purpose of the Study:

• To review the current landscape of invasive fungal infections in lung transplant recipients.
• To discuss the evolving diagnostic approaches for fungal infections.
• To highlight the challenges and future directions in antifungal prophylaxis and treatment.

Main Methods:

• Literature review of recent studies on fungal infections in lung transplantation.
• Analysis of diagnostic trends, including molecular methods.
• Examination of current and emerging antifungal agents and prophylaxis strategies.

Main Results:

• Candida and Aspergillus species are the most common fungal pathogens in lung transplant recipients.
• Molecular diagnostics are increasingly complementing traditional methods for early detection.
• Development of antifungal resistance and novel therapeutic agents are shaping treatment paradigms.

Conclusions:

• Effective management of IFIs in lung transplant recipients requires a multifaceted approach.
• Continued research into novel diagnostics and antifungals is essential to overcome resistance and improve survival.
• Optimizing prophylaxis and treatment strategies remains a priority for lung transplant programs.